Lymphangiosarcoma of the Thorax and Thoracic Vertebrae in a 16-Year-Old Girl

3333 Burnet Ave, MLC 7015, Cincinnati, OH 45229
Journal of Clinical Oncology (Impact Factor: 18.43). 08/2012; 30(29):e294-8. DOI: 10.1200/JCO.2012.42.4531
Source: PubMed
Download full-text


Available from: Anita Gupta
  • [Show abstract] [Hide abstract]
    ABSTRACT: Vascular tumors are rare in children and adults. Classification of these tumors has been difficult, especially in the pediatric population, due to the rarity of these lesions, the unusual morphologic appearance, their diverse clinical behavior and no independent stratification for pediatric tumors. In 2013, The World Health Organization updated the classification of soft tissue vascular tumors. Pediatric tumors were not independently stratified and the terminology was mostly left unchanged but the intermediate category of tumors was divided into locally aggressive and rarely metastasizing. These tumors are treated with multimodality therapy and therefore need the guidance of an interdisciplinary team for best care.
    No preview · Article · Aug 2014 · Seminars in Pediatric Surgery
  • [Show abstract] [Hide abstract]
    ABSTRACT: Angiosarcoma/lymphangiosarcoma is a rare malignancy with poor prognosis. We generated a mouse model with inducible endothelial-cell-specific deletion of Tsc1 to examine mTORC1 signaling in lymphangiosarcoma. Tsc1 loss increased retinal angiogenesis in neonates and led to endothelial proliferative lesions from vascular malformations to vascular tumors in adult mice. Sustained mTORC1 signaling was required for lymphangiosarcoma development and maintenance. Increased VEGF expression in tumor cells was seen, and blocking autocrine VEGF signaling abolished vascular tumor development and growth. We also found significant correlations between mTORC1 activation and VEGF, HIF1α, and c-Myc expression in human angiosarcoma samples. These studies demonstrated critical mechanisms of aberrant mTORC1 activation in lymphangiosarcoma and validate the mice as a valuable model for further study. Sun etal. show that lymphangiosarcoma with clinical and molecular features of human tumors develop in mice with inducible endothelial-cell-specific deletion of Tsc1. Importantly, they show that sustained mTORC1 and VEGFR activities are required for tumor maintenance; inhibition of either reduces tumor growth.
    No preview · Article · Nov 2015 · Cancer cell